3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Solid Tumors
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Leukemia, Plasma Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Monocytic, Acute
1
Hodgkin Disease
1
Burkitt Lymphoma
1
Adenocarcinoma, Bronchiolo-Alveolar
1
Adenocarcinoma of Lung
1
Interventions
Temozolomide
4
Cyclophosphamide
4
Vincristine
3
Magnetic Resonance Spectroscopy
3
Ifosfamide
3
Etoposide
3
Doxorubicin
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
ivosidenib
2
cabozantinib
2
X-Rays
2
Topotecan
2
Specimen Handling
2
Radiation
2
Phantoms, Imaging
2
Nuclear Medicine Department, Hospital
2
Irinotecan
2
Eflornithine
2
Congresses as Topic
2
trifluridine tipiracil drug combination
1
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
liposomal doxorubicin
1
larotrectinib
1
irinotecan sucrosofate
1
ganitumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma, Ewing
×
pegylated granulocyte colony-stimulating factor
×
30 days
×
Clear all
No trials found.